This article explores advanced oligonucleotide analysis techniques, including chromatography methods for therapeutic RNA, ...

Researchers from IOCB Prague have discovered a new type of substances capable of safely transporting various types of nucleic acids used for therapeutic purposes into cells, from basic building blocks ...

The explosion in demand for mRNA vaccines, CRISPR tools and short RNA therapies has made reliable oligonucleotide analysis more important than ever. Agilent’s workflow guide for short nucleic acids ...

Lipid-based nanoparticles (LNPs) are effective non-viral vectors for delivering messenger RNA products (mRNA), most notably used for vaccine production against the recent SARS-CoV-2 pandemic. In this ...

insights from industryStefan CairnsProduct Technical Specialist Malvern Panalytical In this interview, Malvern Panalytical Product Technical Specialist, Dr Stefan Cairns, discusses how size exclusion ...

Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. Syracuse, New York-based Repair Biotechnologies will use Swiss company Genevant’s lipid nanoparticles to usher its ...

Piezo Therapeutics has emerged as the latest startup focused on the delivery of nucleic acids, launching with $2 million in seed funding and a platform that combines electric pulses and microneedles.

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has ...

San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves forward with a broader restructuring plan. TriLink is letting go of 69 employees ...